mRNA Synthesis Raw Materials Market Is Slated To Witness Tremendous Growth In Future

mRNA Synthesis Raw Materials Market Summary

The global mRNA synthesis raw materials market size was estimated at USD 1.67 billion in 2024 and is projected to reach USD 2.30 billion by 2030, growing at a CAGR of 5.78% from 2025 to 2030. mRNA, or messenger RNA, is synthesized through the biological process of transcription inside the cell nucleus, using a DNA nucleotide sequence as the template.

This synthesis process involves multiple steps including initiation, elongation, editing, and termination to produce a functional mRNA strand. The availability and quality of raw materials used in this process play a key role in ensuring high accuracy and efficiency in mRNA production. mRNA-based platforms have gained significant attention due to their wide range of applications in drug discovery, vaccine development, and therapeutic manufacturing. Their ability to enable rapid design, targeted action, and personalized treatment is increasing demand for premium-quality synthesis components such as nucleotides, enzymes, and reagents.

Key Market Trends & Insights

• North America mRNA synthesis raw material market held the largest share of 36.13% of the global market in 2024, driven by strong research infrastructure, robust biotechnology investments, and rising healthcare innovation.
• The mRNA synthesis raw material market in the U.S. is expected to grow significantly over the forecast period due to growing emphasis on advanced vaccine manufacturing and expansion of domestic biopharmaceutical capabilities.
• By type, the nucleotides segment held the highest market share of 37.06% in 2024 owing to the constant requirement of high-purity nucleotides for reliable mRNA production processes.
• Based on application, the vaccine production segment held the highest market share in 2024, supported by extensive adoption of mRNA technology for infectious disease prevention and pandemic preparedness.
• By end user, the biopharmaceutical and pharmaceutical companies segment held the highest market share in 2024 as they remain the leading contributors to commercial mRNA-based product development and large-scale clinical manufacturing.

Order a free sample PDF of the mRNA Synthesis Raw Materials Market Intelligence Study, published by Grand View Research.

Market Size & Forecast

• 2024 Market Size: USD 1.67 Billion
• 2030 Projected Market Size: USD 2.30 Billion
• CAGR (2025-2030): 5.78%
• North America: Largest market in 2024
• Asia Pacific: Fastest growing market

Key Companies & Market Share Insights

Key players operating in the mRNA synthesis raw material indudtry are undertaking various initiatives to strengthen their presence and increase the reach of their products and services. Strategies such as expansion activities and partnerships are key in propelling the market growth.

Key Players

• Hoffmann-La Roche Ltd.
• Jena Bioscience GmbH
• Merck KGaA
• Yeasen Biotechnology (Shanghai) Co., Ltd.
• BOC Sciences
• Thermo Fisher Scientific, Inc.
• Maravai LifeSciences
• New England Biolabs
• Creative Biogene

Explore Horizon Databook – The world's most expansive market intelligence platform developed by Grand View Research.

Conclusion

In conclusion, the global mRNA synthesis raw materials market is witnessing steady growth as mRNA technology continues to transform the biopharmaceutical landscape. This market expansion is driven by rising application of mRNA in vaccines, therapeutics, and precision medicine, along with rapid advancements in transcription-based platform technologies. Strong demand from major pharmaceutical companies and increased funding for biotechnology research further support market progress. North America remains a dominant region due to its established manufacturing ecosystem and strategic regulatory support. Continued innovation in high-quality synthesis inputs and production techniques is expected to play a crucial role in enabling efficient development of next-generation mRNA-based medical solutions.